By Conor Coyle
Date: Tuesday 06 Sep 2016
(ShareCast News) - US manufacturing company Danaher Corp. is set to buy molecular diagnostics firm Cepheid in a deal worth around $4bn including debt.
No recent information was found.
Currency | US Dollars |
Share Price | $ 203.20 |
Change Today | $ 0.70 |
% Change | 0.35 % |
52 Week High | $280.76 |
52 Week Low | $174.64 |
Volume | 999 |
Shares Issued | 719.10m |
Market Cap | $146,121m |
Beta | 0.94 |
RiskGrade | 135 |
Strong Buy | 12 |
Buy | 8 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 24 |
Time | Volume / Share Price |
13:00 | 247,549 @ $203.20 |
13:00 | 181 @ $202.89 |
13:00 | 500 @ $202.89 |
12:59 | 377 @ $203.11 |
12:59 | 100 @ $203.07 |
You are here: research